These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1338387)

  • 1. Fluoxetine increases insulin action in obese type II (non-insulin dependent) diabetic patients.
    Potter van Loon BJ; Radder JK; Frölich M; Krans HM; Zwinderman AH; Meinders AE
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S55-61. PubMed ID: 1338387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals.
    Potter van Loon BJ; Radder JK; Frölich M; Krans HM; Zwinderman AH; Meinders AE
    Int J Obes Relat Metab Disord; 1992 Feb; 16(2):79-85. PubMed ID: 1316330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of obesity on insulin action in NIDDM.
    Campbell PJ; Carlson MG
    Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss.
    Maheux P; Ducros F; Bourque J; Garon J; Chiasson JL
    Int J Obes Relat Metab Disord; 1997 Feb; 21(2):97-102. PubMed ID: 9043962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.
    Scheen AJ; Paolisso G; Salvatore T; Lefèbvre PJ
    Diabetes Care; 1991 Apr; 14(4):325-32. PubMed ID: 2060435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized double-blind clinical trial of fluoxetine in obese diabetics.
    Gray DS; Fujioka K; Devine W; Bray GA
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S67-72. PubMed ID: 1338389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimates of insulin action in normal, obese and NIDDM man: comparison of insulin and glucose infusion test, CIGMA, minimal model and glucose clamp techniques.
    Davis SN; Monti L; Piatti PM; Moller N; Ng L; Coppack S; May M; Brown MD; Orskov H; Alberti KG
    Diabetes Res; 1993; 23(1):1-18. PubMed ID: 7924144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added benfluorex in obese insulin-requiring type 2 diabetes.
    Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
    Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.
    Utriainen T; Takala T; Luotolahti M; Rönnemaa T; Laine H; Ruotsalainen U; Haaparanta M; Nuutila P; Yki-Järvinen H
    Diabetologia; 1998 May; 41(5):555-9. PubMed ID: 9628273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
    Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G
    Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo action of glibenclamide in obese subjects with mild type 2 (non-insulin dependent) diabetes.
    Hother-Nielsen O; Schmitz O; Andersen PH; Pedersen O; Beck-Nielsen H
    Diabetes Res; 1988 Jun; 8(2):63-70. PubMed ID: 3147830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.
    Efendic S; Karlander S; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1953-61. PubMed ID: 3290257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of thermogenic response to glucose/insulin infusion in diabetic obese subjects.
    Golay A; Schutz Y; Felber JP; de Fronzo RA; Jéquier E
    Int J Obes; 1986; 10(2):107-16. PubMed ID: 3522450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.
    Koska J; Ortega E; Bunt JC; Gasser A; Impson J; Hanson RL; Forbes J; de Courten B; Krakoff J
    Diabetologia; 2009 Mar; 52(3):385-93. PubMed ID: 19104769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance in obesity and noninsulin dependent diabetes mellitus.
    Wang LM; Wu MS; Fung TJ; Ho T; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jan; 43(1):15-20. PubMed ID: 2766059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter study.
    Daubresse JC; Kolanowski J; Krzentowski G; Kutnowski M; Scheen A; Van Gaal L
    Obes Res; 1996 Jul; 4(4):391-6. PubMed ID: 8822764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.